LMG Life Sciences 2017 Honors WilmerHale With Top Rankings

LMG Life Sciences 2017 Honors WilmerHale With Top Rankings

Firm News

LMG Life Sciences has recognized WilmerHale among the nation's leading life sciences law firms in its 2017 rankings, citing the firm's Life Sciences Practice as “renowned for its range and multidisciplinary teams that counsel clients in biotechnology, pharmaceutical and medical device companies as well as investment banks and venture capitalists.” The firm earned high praise in several categories and has 15 partners individually honored as Life Sciences Stars:

Intellectual Property
Patent Prosecution – Recommended
Patent Strategy and Management – Highly Recommended
General Patent Litigation – Highly Recommended
Hatch-Waxman Patent Litigation (Branded) – Highly Recommended

Finance and Transactional
Corporate – Recommended
Licensing and Collaboration – Highly Recommended
Mergers and Acquisitions – Recommended
Venture Capital – Recommended

Non-IP Litigation 
White Collar/Government Investigation – Recommended

Life Sciences Stars
Steven Barrett
David Bassett
Michael Bongiorno
Robert Gunther 
Brent Gurney
Stephen Jonas
Belinda Juran
William Lee
Lisa Pirozzolo
Emily Schulman
Mark Selwyn 
Steven Singer
Colleen Superko
Emily Whelan 
Amy Wigmore

LMG Life Sciences, a legal directory guide focusing on US law firms and attorneys who work with life sciences companies, is produced by the Legal Media Group, and its editorial structure is divided into categories that cover traditional practice areas that relate to life sciences. Research for the publication was based on interviews and surveys completed by leading lawyers and clients who are active in the market.

View LMG's complete list of 2017 US law firm and lawyer rankings.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.